Clayton Fletcher
About Clayton Fletcher
Clayton Fletcher is the Chief Business Development Officer at BioCryst, bringing over 25 years of experience in the biopharmaceutical industry from various leading companies.
Chief Business Development Officer at BioCryst
Clayton Fletcher currently holds the position of Chief Business Development Officer at BioCryst. He brings over 25 years of experience in the biopharmaceutical industry to this role. His extensive background in business development makes him a valuable asset to the company.
Previous Role at Idera Pharmaceuticals
Before joining BioCryst, Clayton Fletcher was the Senior Vice President of Business Development & Strategic Planning at Idera Pharmaceuticals, Inc. In this role, he was responsible for evaluating and executing various business development activities. His duties included valuation, due diligence, licensing, acquisition, and contract negotiations, showcasing his comprehensive expertise in strategic business dealings.
Business Development Leadership at ViroPharma Inc.
Clayton Fletcher served as the Vice President of Business Development & Project Management at ViroPharma Inc. During his tenure, he oversaw the acquisition of Cinryze from LEV Pharmaceuticals. His leadership in business development and project management played a crucial role in the successful acquisition and integration of new assets into ViroPharma's portfolio.
Career at SmithKline Beecham Pharmaceuticals and GlaxoSmithKline
Clayton Fletcher held multiple roles of escalating responsibility at SmithKline Beecham Pharmaceuticals, later GlaxoSmithKline. His tenure at these companies provided him with a solid foundation in the biopharmaceutical industry, equipping him with diverse experiences in business development and project management.
Educational Background in Biology
Clayton Fletcher received both his B.S. and M.S. degrees in biology from Wake Forest University in 1985 and 1990, respectively. His educational background provided him with a strong scientific foundation, which he has effectively integrated into his business development expertise over his extensive career.